Market Cap : 739.19 M | Enterprise Value : 672.14 M | PE Ratio : At Loss | PB Ratio : 1.21 |
---|
NAS:SLGC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SLGC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:
We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.
Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.
As of today (2022-08-09), SomaLogic's share price is $4.07. SomaLogic's GF Value is $0.00. Therefore, SomaLogic's Price-to-GF-Value for today is .
Based on the relationship between the current stock price and the GF Value, GuruFocus believes SomaLogic is Not Valued.
Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:
Posssible Evaluations | All-in-One Screener Examples (2) |
Possible Value Trap, Think Twice (1) | Predictable Companies that possibly be Value Traps |
Significantly Overvalued | Predictable Companies which are Significantly Overvalued |
Modestly Overvalued | Predictable Companies which are Modestly Overvalued |
Fairly Valued | Predictable High Quality Companies which are Fairly Valued |
Modestly Undervalued (3) | Predictable High Quality Companies which are Modestly Undervalued |
Significantly Undervalued (3) | Predictable High Quality Companies which are Significantly Undervalued |
(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.
(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.
(3) There is only a sufficient margin of safety when the stock is undervalued.
SomaLogic's Price-to-GF-Value for today is calculated as
Price-to-GF-Value | = | Share Price | / | GF Value |
= | 4.07 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of SomaLogic's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Blakeman Shaun M. | officer: Chief Financial Officer | C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424 |
Margulies Anne H. | director | C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747 |
Post Richard A | director | 998 LACOSTA LANE LANE TREE CO 80124 |
Casdin Eli | director | 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019 |
Cox Troy | director | C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141 |
Meisel Ted D | director | |
Barchi Robert | director | |
Quake Stephen | director | C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080 |
Lillis Charles M. | director | 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108 |
Harris Melody | officer: President and COO | 4801 WEST BYRON PLACE DENVER CO 80211 |
Gutierrez Ruben | officer: General Counsel | 6435 AVENIDA WILFREDO LA JOLLA CA 92037 |
Graves Amy | officer: Chief Accounting Officer | 926 PENDLETON AVENUE LONGMONT CO 80504 |
Smythe Roy | director, officer: Chief Executive Officer | 935 10TH STREET BOULDER CO 80302 |
M-lsh Ii Llc | 10 percent owner | 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065 |
C-lsh Ii Llc | 10 percent owner | 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019 |
From GuruFocus
Other Sources
By Seekingalpha 2021-11-15
By Seekingalpha 2021-10-14
By Seekingalpha 2022-01-11
By Zacks 2022-02-17